Preferred Drug List Changes
The following changes have been made to the Nebraska Preferred Drug List Changes (PDL).
| Nebraska PDL Therapeutic Drug Class | Brand Name (Route) | PDL Status before 07/17/2026 | PDL status on or after 07/17/2026 |
|---|---|---|---|
| ANDROGENIC AGENTS | TESTOSTERONE GEL PACKET (AG) (VOGELXO) (TRANSDERM) | Non-Preferred | Preferred |
| ANGIOTENSIN MODULATORS | ENTRESTO (ORAL) | Preferred | Non-Preferred |
| ANTIBIOTICS, GI | VANCOMYCIN CAPSULE (AG) (ORAL) | Non-Preferred | Preferred |
| ANTIBIOTICS, GI | VANCOMYCIN CAPSULE (ORAL) | Non-Preferred | Preferred |
| ANTIBIOTICS, VAGINAL | CLINDAMYCIN (VAGINAL) | Non-Preferred | Preferred |
| ANTIBIOTICS, VAGINAL | CLEOCIN CREAM (VAGINAL) | Preferred | Non-Preferred |
| ANTICOAGULANTS | ELIQUIS SPRINKLE (ORAL) | Non-Preferred | Preferred |
| ANTICOAGULANTS | ELIQUIS SUSPENSION (ORAL) | Non-Preferred | Preferred |
| ANTICOAGULANTS | DABIGATRAN (ORAL) | Preferred | Non-Preferred |
| ANTIFUNGALS, TOPICAL | TOLNAFTATE POWDER OTC (TOPICAL) | Non-Preferred | Preferred |
| ANTIFUNGALS, TOPICAL | TOLNAFTATE SPRAY OTC (TOPICAL) | Non-Preferred | Preferred |
| ANTIMIGRAINE AGENTS, TRIPTANS | NARATRIPTAN (ORAL) | Non-Preferred | Preferred |
| ANTIPARASITICS, TOPICAL | SPINOSAD (AG) (TOPICAL) | Non-Preferred | Preferred |
| CALCIUM CHANNEL BLOCKERS | NORLIQVA (ORAL) | Non-Preferred | Preferred |
| GLUCAGON AGENTS | GVOKE VIAL (SUBCUTANEOUS) | Non-Preferred | Preferred |
| GLUCAGON AGENTS | GLUCAGON EMERGENCY KIT (MYLAN) (INJECTION) | Preferred | Non-Preferred |
| HIV / AIDS | DARUNAVIR (ORAL) | Non-Preferred | Preferred |
| HIV / AIDS | EMTRICITABINE CAPSULE (ORAL) | Non-Preferred | Preferred |
| HIV / AIDS | MARAVIROC TABLET (ORAL) | Non-Preferred | Preferred |
| HIV / AIDS | EMTRIVA CAPSULE (ORAL) | Preferred | Non-Preferred |
| HIV / AIDS | NORVIR TABLET (ORAL) | Preferred | Non-Preferred |
| HIV / AIDS | PREZISTA (ORAL) | Preferred | Non-Preferred |
| HIV / AIDS | SELZENTRY TABLET (ORAL) | Preferred | Non-Preferred |
| HYPOGLYCEMICS, INCRETIN MIMETICS/ENHANCERS | JANUMET XR (ORAL) | Preferred | Non-Preferred |
| HYPOGLYCEMICS, INSULIN AND RELATED AGENTS | HUMALOG CARTRIDGE (SUBCUTANE.) | Non-Preferred | Preferred |
| HYPOGLYCEMICS, INSULIN AND RELATED AGENTS | HUMALOG JUNIOR KWIKPEN (SUBCUTANE.) | Non-Preferred | Preferred |
| HYPOGLYCEMICS, INSULIN AND RELATED AGENTS | HUMALOG MIX PEN (SUBCUTANE.) | Non-Preferred | Preferred |
| HYPOGLYCEMICS, INSULIN AND RELATED AGENTS | HUMALOG PEN (SUBCUTANE.) | Non-Preferred | Preferred |
| HYPOGLYCEMICS, INSULIN AND RELATED AGENTS | HUMALOG VIAL (SUBCUTANE.) | Non-Preferred | Preferred |
| LIPOTROPICS, OTHER | ICOSAPENT ETHYL (ORAL) | Non-Preferred | Preferred |
| MACROLIDES/KETOLIDES | ERYTHROMYCIN ETHYLSUCCINATE 200 SUSPENSION (AG) (ORAL) | Non-Preferred | Preferred |
| MACROLIDES/KETOLIDES | ERYTHROMYCIN ETHYLSUCCINATE 200 SUSPENSION (ORAL) | Non-Preferred | Preferred |
| MACROLIDES/KETOLIDES | AZITHROMYCIN PACKET (AG) (ORAL) | Preferred | Non-Preferred |
| MACROLIDES/KETOLIDES | E.E.S. 200 SUSPENSION (ORAL) | Preferred | Non-Preferred |
| PHOSPHATE BINDERS | CALCIUM ACETATE TABLET (ORAL) | Preferred | Non-Preferred |
| PLATELET AGGREGATION INHIBITORS | BRILINTA (ORAL) | Preferred | Non-Preferred |
| SKELETAL MUSCLE RELAXANTS | CHLORZOXAZONE (ORAL) | Preferred | Non-Preferred |
| VASODILATORS, CORONARY | ISOSORBIDE DINIT/HYDRALAZINE TABLET (AG) (ORAL) | Preferred | Non-Preferred |
| Nebraska PDL Therapeutic Drug Class | Drug Name (Route) | PDL Status before 1/16/26 | PDL status on or after 1/16/26 |
|---|---|---|---|
| ANTIPARKINSON'S AGENTS | ENTACAPONE (ORAL) | Non-Preferred | Preferred |
| CYTOKINE AND CAM ANTAGONISTS | HADLIMA KIT (INJECTION) (CF) 100 MG/ML | Non-Preferred | Preferred |
| CYTOKINE AND CAM ANTAGONISTS | HADLIMA KIT (INJECTION) 50 MG/ML | Non-Preferred | Preferred |
| CYTOKINE AND CAM ANTAGONISTS | HADLIMA PEN KIT (INJECTION) (CF) 100 MG/ML | Non-Preferred | Preferred |
| CYTOKINE AND CAM ANTAGONISTS | HADLIMA PEN KIT (INJECTION) 50 MG/ML | Non-Preferred | Preferred |
| CYTOKINE AND CAM ANTAGONISTS | SIMLANDI PEN KIT (INJECTION) (CF) 100 MG/ML | Non-Preferred | Preferred |
| CYTOKINE AND CAM ANTAGONISTS | TALTZ AUTOINJECTOR (SUBCUTANE.) | Non-Preferred | Preferred |
| CYTOKINE AND CAM ANTAGONISTS | TALTZ SYRINGE (SUBCUTANE.) | Non-Preferred | Preferred |
| CYTOKINE AND CAM ANTAGONISTS | PYZCHIVA SYRINGE (SUBCUTANEOUS) | Non-Preferred | Preferred |
| CYTOKINE AND CAM ANTAGONISTS | STEQEYMA SYRINGE (SUBCUTANE.) | Non-Preferred | Preferred |
| IMMUNOMODULATORS, ATOPIC DERMATITIS | EBGLYSS PEN (SUBCUTANEOUS) | Non-Preferred | Preferred |
| IMMUNOMODULATORS, ATOPIC DERMATITIS | EBGLYSS SYRINGE (SUBCUTANEOUS) | Non-Preferred | Preferred |
| ANTIPARKINSON'S AGENTS | CARBIDOPA/LEVODOPA/ENTACAPONE (ORAL) | Preferred | Non-Preferred |
| CYTOKINE AND CAM ANTAGONISTS | COSENTYX PEN (SUBCUTANE.) | Preferred | Non-Preferred |
| CYTOKINE AND CAM ANTAGONISTS | COSENTYX SYRINGE (SUBCUTANE.) | Preferred | Non-Preferred |
| CYTOKINE AND CAM ANTAGONISTS | CYLTEZO KIT (INJECTION) (CF) 100 MG/ML | Preferred | Non-Preferred |
| CYTOKINE AND CAM ANTAGONISTS | CYLTEZO KIT (INJECTION) (CF) 50 MG/ML | Preferred | Non-Preferred |
| CYTOKINE AND CAM ANTAGONISTS | CYLTEZO PEN KIT (INJECTION) (CF) 100 MG/ML | Preferred | Non-Preferred |
| CYTOKINE AND CAM ANTAGONISTS | CYLTEZO PEN KIT (INJECTION) (CF) 50 MG/ML | Preferred | Non-Preferred |
| CYTOKINE AND CAM ANTAGONISTS | HUMIRA KIT (INJECTION) (CF) 100 MG/ML | Preferred | Non-Preferred |
| CYTOKINE AND CAM ANTAGONISTS | HUMIRA KIT (INJECTION) 50 MG/ML | Preferred | Non-Preferred |
| CYTOKINE AND CAM ANTAGONISTS | HUMIRA PEN KIT (INJECTION) (CF) 100 MG/ML | Preferred | Non-Preferred |
| CYTOKINE AND CAM ANTAGONISTS | HUMIRA PEN KIT (INJECTION) 50 MG/ML | Preferred | Non-Preferred |
| STIMULANTS AND RELATED AGENTS | ADDERALL XR (ORAL) | Preferred | Non-Preferred |